Videos

Bruce A. Berger, PhD, president of Berger Consulting LLC, discusses how motivational interviewing plays into value-based care.

Doug Long, vice president of industry relations at IMS Health, discusses if health care providers will be hesitant to prescribe biosimilars.

Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses the biggest roadblocks to managing COPD and how pharmacists can help overcome those challenges.

Doug Long, vice president of industry relations at IMS Health, talks about the most significant market trend in the pharmaceutical industry so far in 2015.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses how new technologies will enhance the ability of a community pharmacist to support medication adherence.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses how socioeconomic factors affect adherence.

Paul Greenall, senior vice president of strategy and business development at McKesson Corporation, talks about how he sees the role of the pharmacist changing in the next few years.

Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses problems associated with automation in the pharmacy dispensing process.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses the projected ramifications from the launch of biosimilars in the United States.

Bruce A. Berger, PhD, president of Berger Consulting LLC, discusses the barriers pharmacists face in utilizing motivational interviewing techniques.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses what community pharmacists can do to contribute to improving communication and patient care on transition teams.

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses what patients should know about Afrezza.

Kristen L. Marjama, DNP, MSN, FNP-BC, clinical educator with Healthcare Clinic at Walgreens in Fort Lauderdale, Florida, discusses counseling points that pharmacists can provide to patients on asthma medications.

Paul Greenall, senior vice president of strategy and business development at McKesson Corporation, talks about how his company supports the expanding role of the pharmacist.

Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses some techniques pharmacists can demonstrate for inhaled medications like Dulera and Symbicort.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about some ways smoking cessation can improve patient health and manage chronic conditions.

Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, talks obstacles to managing diabetes, and how pharmacists overcome them.

Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses legislative issues and technology that could affect pharmacy.

Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses how community pharmacists can best leverage EHR technology.

Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research and associate professor at Wilkes University, discusses communication obstacles that hinder community pharmacists from playing a more active role in transitions of care.

Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses potential barriers to inhaled insulin, like Afrezza.

This weekly video program highlights the latest in pharmacy news product news, and more.

Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, gives counseling points that pharmacists should provide to diabetic patients.

Chris Hatwig, MS, FASHP of Apexus discusses what health-system pharmacists need to know about the potential for HRSA audits to review 340B program compliance requirements.

Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses some counseling points pharmacists can provide to patients on COPD medications.

Bruce Berger, PhD, president of Berger Consulting LLC, discusses the behavioral patterns that contribute to a patient's propensity to be more or less adherent to their medications.

Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about some current trends in state protocols related to pharmacists' abilities to dispense smoking cessation products.

Chris Hatwig, MS, FASHP of Apexus discusses how split billing software helps to keep contract pharmacies organized with respect to 340B requirements.

Chris Hatwig, MS, FASHP of Apexus discusses what HRSA policy updates, including 340B "mega guidance," are poised to affect health-system pharmacists.

Paul Sipes, vice president of Spud Software, discusses how specialty pharmacies can benefit from the use of a data warehouse.